BLAKE MENCHACA: Open Payments
NPI 1699217547 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 9 payments from 6 companies in 2025. Trend: 2023 $1,165 · 2024 $1,073 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $249 |
| Fresenius Kabi USA, LLC | 1 | $123 |
| La Jolla Pharmaceutical Company | 1 | $122 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
| Amgen Inc. | 1 | $101 |
| ABBVIE INC. | 3 | $54 |
Products named: ZERBAXA, Smoflipid, ZEVTERA, TERLIVAZ, AVYCAZ, TEFLARO.
Industry payments across TX — which companies pay providers there.
